1. @Bricgray $0 = next to impossible, it will be hard to even get pass the major support of $6.35 area. $AMRN

  2. But we aren t.. $Amrn burning cash..

  3. @Bricgray: $AMRN But wouldn t it be far safer to buy once money drain stops and they become self sustaining? // were at that point. Buy buy

  4. $amrn .. What I meant to say is zero or 15!

  5. I was long $amrn from 12 down to 9.. I would rather wait and buy it back at 9 when it turns rather than gambling on what may be Zero or 20!

  6. $amrn may not be a bad story long term... But wouldn t it be far safer to buy once money drain stops and they become self sustaining?

  7. $AMRN 1st Generic V not possible until NCE dec. so by default still exclusive. 2nd Most patents good until 2030.

  8. $AMRN EPA protects against 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced hepatic toxicity http://y.ahoo.it/27LcxF0I

  9. $AMRN So anyone can educate me when can the generic V get into the market if we don t get NCE? I thought most the patent is till 2030.

  10. @djvjag: @CaptBeer I don t think $AMRN is a long shot. She s just a slow starter. Watch the home stretch. // good point. Its how you finish

  11. @CaptBeer I don t think $AMRN is a long shot. She s just a slow starter. Watch the home stretch.

  12. Oxbow wins Preakness, like $AMRN A long shot for big money!

  13. @JediInvestor nice pic Jedi. Darth Vector doesn t stand a chance against her! $amrn

  14. $AMRN I would like a solid 3400

  15. $AMRN <--- In it to win it! Looking for a nice jump in scripts this week.

  16. On May 13th, after 6% script growth announced for week prior, $AMRN opened at 7.20, closed at 7.59, up .39. You really have ZERO clue..

  17. $AMRN had 6.7% Rx increase last week, if the number doesn t break 8-9% tomorrow expect $6-6.50 on the fast.

  18. $AMRN JZ mentions http://y.ahoo.it/LXrlfQiL when talking about NCE

  19. @CJswinning BP would have much bigger marketing budget for tv ads & hit the ground running with $AMRN Vascepa on road to 10b+/yr

  20. @CJswinning BP would have much bigger marketing budget for tv ads & hot the ground running with $AMRN Vascela on road to 10b+/yr

  21. But yes even after and during all that there is also huge potential with the off label and gen pop converting from OTC for gen health. $AMRN

  22. meantime though $AMRN Vascepa can concentrate on being a blockbuster drug with no risks/side effects marine sales cont. then anchor & combo

  23. $AMRN I know most of us here believe hangup to a partner/bo is nce... but it just may be combo & anchor NOA related.. only the company knows

  24. $AMRN CJ maybe once they reached a certain threshold w/doc ed. or may wait for anchor for bigger targeting. Ultimately it will be promoted.

  25. $AMRN well there is no doubt WS loves $tsla right now.